Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Outstanding Awards and Exercises (Details)

v3.24.3
Stock-Based Compensation - Outstanding Awards and Exercises (Details)
$ / shares in Units, shares in Thousands, $ in Millions
 9 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Awards | Common stock, all series  
Compensation cost not yet recognized  
Shares reserved for future issuance upon exercise of stock options 4,300
Employee Stock Option  
Compensation cost not yet recognized  
Unrecognized compensation cost options | $ $ 25
Period over which unrecognized compensation cost will be recognized 1 year 10 months 24 days
Employee Stock Option | Series A common stock  
Options  
Options granted (in shares) 0
Outstanding ending balance (in shares) 0
Employee Stock Option | Series B common stock  
Options  
Options granted (in shares) 0
Forfeited/Cancelled (in shares) (150)
Outstanding ending balance (in shares) 96
WAEP  
WAEP options forfeited/cancelled (in dollars per share) | $ / shares $ 97.21
WAEP Outstanding ending balance (in dollars per share) | $ / shares $ 94.05
Options additional disclosures  
Weighted average remaining contractual life outstanding 7 months 6 days
Aggregate intrinsic value outstanding | $ $ 0
Employee Stock Option | Series C common stock  
Options  
Outstanding beginning balance (in shares) 4,063
Options granted (in shares) 183
Outstanding ending balance (in shares) 4,246
Number of awards exercisable (in shares) 3,140
WAEP  
WAEP Outstanding beginning balance (in dollars per share) | $ / shares $ 96.23
WAEP Options granted (in dollars per share) | $ / shares 56.20
WAEP Outstanding ending balance (in dollars per share) | $ / shares 94.51
WAEP options exercisable (in dollars per share) | $ / shares $ 88.48
Options additional disclosures  
Weighted average remaining contractual life outstanding 2 years 6 months
Weighted average remaining contractual life exercisable 1 year 7 months 6 days
Aggregate intrinsic value outstanding | $ $ 48
Aggregate intrinsic value exercisable | $ $ 44
Employee Stock Option | CEO | Series C common stock  
Options  
Options granted (in shares) 183